Showing results (1291-1300 of 1,397) with videos related to
Sort By:
Pageof 140
The Journal of Steroid Biochemistry and Molecular Biology|November 10, 2016
Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UKDavid A Jolliffe, Kate Kilpin, Beverley D MacLaughlin, et al.Genes, Chromosomes & Cancer|May 24, 2023
The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencingMelanie A Jones, Kirsten M Timms, Shanell Hatcher, et al.Cancers|July 26, 2020
Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal WomenAleksandra Gentry-Maharaj, Oleg Blyuss, Andy Ryan, et al.Human Molecular Genetics|August 9, 2006
TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predispositionSteven Stone, Victor Abkevich, Deanna L Russell, et al.Cancer & Metabolism|October 20, 2023
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibitionAmy K Holt, Arafath K Najumudeen, Tracey J Collard, et al.Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Known pathogenic gene variants and new candidates detected in Sudden Unexpected Infant Death using Whole Genome SequencingAngela M Bard, Lindsay V Clark, Erdal Cosgun, et al.The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L Telli, Charles Chu, Sunil S Badve, et al.British Journal of Cancer|October 25, 2018
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genesDarren R Hodgson, Brian A Dougherty, Zhongwu Lai, et al.Cancer Research|May 13, 2020
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific PropertiesLawrence N Barrera, Anthony Evans, Brian Lane, et al.Pageof 140